22 October 2007 20:45 [Source: ICIS news]
TORONTO (ICIS news)--US pharmaceuticals maker Schering-Plough reported on Monday a 143% increase in third-quarter profit but its share price fell 13.60% as the results were below analysts’ expectations.
Net income for the three months ended 30 September was $750m, up from $309m in the 2006 third quarter, on net sales of $2.8bn, up 9.2%.
The company earlier this year acquired Akzo Nobel’s Organon BioSciences business.
The European Commission approved for the acquisition earlier this month and Schering-Plough has completed most of the deal's financing, securing about $9bn through a mix of equity and debt, it said.
Schering-Plough's shares were priced at $28.26 in Monday afternoon trading in ?xml:namespace>
For the latest chemical news, data and analysis that directly impacts your business sign up for a free trial to ICIS news - the breaking online news service for the global chemical industry.
Get the facts and analysis behind the headlines from our market leading weekly magazine: sign up to a free trial to ICIS Chemical Business.
|ICIS news FREE TRIAL|
|Get access to breaking chemical news as it happens.|
|ICIS Global Petrochemical Index (IPEX)|
|ICIS Global Petrochemical Index (IPEX). Download the free tabular data and a chart of the historical index|